Pyrazolyl-ureas as kinase inhibitors
US11142515B2 · kind B2 · utility
0Cited by
33References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 27, 2019 |
| Grant date | Oct 12, 2021 |
| Priority date | — |
| Expiry date | Mar 27, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
There are provided compounds of formula (I) as defined in the specification which are p38 MAP kinase inhibitors for use as medicaments for the treatment inter alia of inflammatory diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.